|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATION (USD $)
|
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Revenues | $ 2,142,932 | $ 1,653,430 | $ 7,691,704 | $ 4,849,470 |
| Cost of goods sold | 560,243 | 439,158 | 1,961,877 | 2,426,544 |
| Gross profit | 1,582,689 | 1,214,272 | 5,729,827 | 2,422,926 |
| Costs and expenses: | ||||
| Sales and marketing | 1,893,541 | 1,628,608 | 6,883,953 | 4,378,694 |
| Research and development | 406,943 | 296,131 | 1,427,211 | 697,355 |
| General and administrative | 1,605,759 | 1,230,608 | 5,220,599 | 4,315,604 |
| Total costs and expenses | 3,906,243 | 3,155,347 | 13,531,763 | 9,391,653 |
| Loss from operations | (2,323,554) | (1,941,075) | (7,801,936) | (6,968,727) |
| Other income (expense): | ||||
| Interest expense | (1,067,621) | (125,125) | (1,391,342) | (1,094,657) |
| Interest expense - deferred financing costs | (44,216) | (34,951) | (986,844) | (1,223,126) |
| Change in fair value of warrant liability | 62,305 | |||
| Other income (expense) | (2,117) | (8,174) | 23,972 | 4,985 |
| Total other income (expense) | (1,113,954) | (168,250) | (2,354,214) | (2,250,493) |
| Loss before income taxes | (10,156,150) | (9,219,220) | ||
| Income tax benefit | 738,192 | |||
| Net loss | (3,437,508) | (2,109,325) | (9,417,958) | (9,219,220) |
| Preferred Stock dividends (assumes all paid) | (1,028,351) | |||
| Net loss attributable to common stockholders | $ (3,437,508) | $ (2,109,325) | $ (9,417,958) | $ (10,247,571) |
| Weighted Average Common Shares outstanding - basic and diluted | 11,124,633 | 11,062,339 | 11,089,425 | 3,697,390 |
| Loss Per Common share - basic and diluted | $ (0.31) | $ (0.19) | $ (0.85) | $ (2.77) |
| X | ||||||||||
|
- Definition
Change in fair value of warrant liability. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average common shares outstanding - basic and diluted. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Definition
Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends). No definition available.
|